Diamyd Medical Revenue and Competitors
Estimated Revenue & Valuation
- Diamyd Medical's estimated annual revenue is currently $9.4M per year.
- Diamyd Medical's estimated revenue per employee is $201,000
Employee Data
- Diamyd Medical has 47 Employees.
- Diamyd Medical grew their employee count by 2% last year.
Diamyd Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Medical and Business Officer | Reveal Email/Phone |
4 | Quality Assurance Manager | Reveal Email/Phone |
5 | Site Manager | Reveal Email/Phone |
6 | US Site Relations and Patient Recruitment Lead | Reveal Email/Phone |
7 | Clinical Program Lead | Reveal Email/Phone |
8 | President & CEO | Reveal Email/Phone |
9 | Process Engineer | Reveal Email/Phone |
10 | Production Scientist | Reveal Email/Phone |
Diamyd Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.1M | 85 | -21% | N/A | N/A |
#2 | $99.7M | 496 | 22% | N/A | N/A |
#3 | $22.9M | 114 | -67% | N/A | N/A |
#4 | $27.3M | 136 | 7% | N/A | N/A |
#5 | $20.9M | 104 | 28% | N/A | N/A |
#6 | $103.1M | 513 | 4% | N/A | N/A |
#7 | $9.4M | 47 | 2% | N/A | N/A |
#8 | $2.4M | 12 | -20% | N/A | N/A |
#9 | $28.1M | 140 | 27% | N/A | N/A |
#10 | $5M | 25 | 4% | N/A | N/A |
What Is Diamyd Medical?
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively in-licensed GAD molecule. In-licensed technologies for GABA and Gliadin also have potential to become a key piece of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes and other inflammation-related conditions. Diamyd Medical's share is traded on Nasdaq Stockholm First North, ticker DMYD B.
keywords:N/A
N/A
Total Funding
47
Number of Employees
$9.4M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diamyd Medical News
Diamyd Medical develops precision medicine therapies for type 1 diabetes. The diabetes vaccine Diamyd® is an antigen-specific immunotherapy...
Diamyd Medical AB, of Stockholm, highlighted an update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes...
Diamyd Medical AB (publ) (STO:DMYD B) insiders who sold earlier this year missed the bus as stock gained 11% last week · The Last 12 Months Of...
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.8M | 47 | 2% | N/A |
#2 | $5.5M | 47 | -24% | N/A |
#3 | N/A | 47 | 24% | N/A |
#4 | N/A | 47 | -16% | N/A |
#5 | $4.9M | 47 | 27% | N/A |